Petrichor Healthcare Capital Management (investor - Private Equity)

United States
See something wrong or missing? Let us know
Offices:New York
Average round investment:65.9M USD
Average number per year:1.0
Distribution: 2023 (1)
Portfolio companies: United Kingdom Ascend Gene & Cell Therapies
Mostly invests in: United Kingdom United Kingdom (1) Biotech (1)

1 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Petrichor Healthcare Capital Management

Name Criteria
China GT Healthcare Capital
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Abingworth
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Japan Ajinomoto
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Tekla Capital Management
83%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Switzerland Julius Bär Group
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Cowen Healthcare Investments
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Artis Ventures
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Deerfield Management
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States What If Ventures
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Arch Venture Partners
82%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Top